Intelligence · Clinical Development
Pipeline search results
Programs matching “aldesleukin” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 12 pipeline programs matching "aldesleukin" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
Bempegaldesleukin
Nektar Therapeutics UK Limited
Melanoma
1 trial -
Bempegaldesleukin
Nektar Therapeutics UK Limited
Metastatic Head and Neck Cancer
1 trial -
bempegaldesleukin
Nektar Therapeutics UK Limited
Renal Cell Carcinoma
1 trial -
ALDESLEUKIN , TIL cells
Disc Medicine
Ovarian carcinoma
1 trial -
ALDESLEUKIN for Germ Cell Tumors refractory to salvage chemotherapy
The George Institute
Germ Cell Tumors refractory to salvage chemotherapy
1 trial -
Aldesleukin
Iovance Biotherapeutics B.V.
Bone Sarcoma
1 trial -
Aldesleukin
United Therapeutics Europe Ltd
Type 1 Diabetes
1 trial -
Bempegaldesleukin
Nektar Therapeutics UK Limited
Urinary Bladder Neoplasm
1 trial -
Rezpegaldesleukin
Nektar Therapeutics UK Limited
Alopecia Areata
1 trial -
Rezpegaldesleukin
Nektar Therapeutics UK Limited
Moderate to Severe Atopic Dermatitis
1 trial -
Bempegaldesleukin
Nektar Therapeutics UK Limited
Covid-19
1 trial -
Bempegaldesleukin (NKTR-214)
Nektar Therapeutics UK Limited
Metastatic Melanoma
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.